Our findings confirm the possibility of the occurrence of internal mammary artery aneurysms in patients with <i>FBN1</i> mutation and we believe that monitoring these aneurysms with blood pressure management can be a suitable option in selected cases. The gene discussed is FBN1; the disease is aneurysm.